AGN-199201 for the Treatment of Erythema With Rosacea



Status:Completed
Conditions:Cosmetic, Dermatology
Therapuetic Areas:Dermatology / Plastic Surgery
Healthy:No
Age Range:18 - Any
Updated:3/30/2013
Start Date:December 2012
End Date:November 2013
Contact:Allergan Inc.
Email:clinicaltrials@allergan.com

Use our guide to learn which trials are right for you!


This study will evaluate the safety and efficacy of 3 doses of AGN-199201 once and twice
daily compared to vehicle for the treatment of moderate to severe facial erythema associated
with rosacea.


Inclusion Criteria:

- Redness of the skin caused by rosacea

Exclusion Criteria:

- ≥3 inflammatory lesions

- Laser light-source or other energy based therapy in the last 6 months

- Any prescription or over the counter product for the treatment of acne or rosacea in
the last 14 days
We found this trial at
1
site
?
mi
from
Dallas, TX
Click here to add this to my saved trials